Life Technologies to Distribute Luminex's Magpix | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex announced after the close of the market Wednesday that Life Technologies will sell and distribute the firm's Magpix instrument worldwide.

Magpix, which was launched last year, is a compact multiplex analyzer that rapidly detects 50 different analytes simultaneously on a single sample, including proteins and nucleic acids. The system is based on Luminex's xMAP technology and provides nearly 5,000 data points in under an hour.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.